dc.contributor.author |
Furtado, Remo H. M. |
|
dc.contributor.author |
Berwanger, Otavio. |
|
dc.contributor.author |
Fonseca, Henrique A. |
|
dc.contributor.author |
Corrêa, Thiago D. |
|
dc.contributor.author |
Ferraz, Leonardo R. |
|
dc.contributor.author |
Lapa, Maura G. |
|
dc.contributor.author |
Zampieri, Fernando G. |
|
dc.contributor.author |
Veiga, Viviane C. |
|
dc.contributor.author |
Azevedo, Luciano C. P. |
|
dc.contributor.author |
Rosa, Regis G. |
|
dc.contributor.author |
Lopes, Renato D. |
|
dc.contributor.author |
Avezum, Alvaro |
|
dc.contributor.author |
Manoel, Airton L. O. |
|
dc.contributor.author |
Piza, Felipe M. T. |
|
dc.contributor.author |
Martins, Priscilla A. |
|
dc.contributor.author |
Lisboa, Thiago |
|
dc.contributor.author |
Pereira, Adriano J. |
|
dc.contributor.author |
Olivato, Guilherme B. |
|
dc.contributor.author |
Dantas, Vicente C. S. |
|
dc.contributor.author |
Milan, Eveline P. |
|
dc.contributor.author |
Gebara, Otavio C. E. |
|
dc.contributor.author |
Amazonas, Roberto B. |
|
dc.contributor.author |
Oliveira, Monalisa B. |
|
dc.contributor.author |
Soares, Ronaldo V. P. |
|
dc.contributor.author |
Moia, Diogo D. F. |
|
dc.contributor.author |
Piano, Luciana P. A. |
|
dc.contributor.author |
Castilho, Kleber |
|
dc.contributor.author |
Momesso, Roberta G. R. A. P. |
|
dc.contributor.author |
Schettino, Guilherme P. P. |
|
dc.contributor.author |
Rizzo, Luiz Vicente |
|
dc.contributor.author |
Serpa Neto, Ary |
|
dc.contributor.author |
Machado, Flávia R . |
|
dc.contributor.author |
Cavalcanti, Alexandre B. |
|
dc.date.accessioned |
2021-07-12T12:45:41Z |
|
dc.date.available |
2021-07-12T12:45:41Z |
|
dc.date.issued |
2020 |
|
dc.identifier.citation |
FURTADO, R. H. M. et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet, v. 396, n. 10256, p. 959-967, 2018. Disponível em: http://hdl.handle.net/11690/1788. Acesso em: 09 jul. 2021. |
pt_BR |
dc.identifier.uri |
http://hdl.handle.net/11690/1788 |
|
dc.language.iso |
en_US |
pt_BR |
dc.publisher |
Elsevier |
pt_BR |
dc.rights |
Open Access |
en |
dc.subject |
COVID-19 |
pt_BR |
dc.subject |
Azithromycin |
pt_BR |
dc.title |
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial |
pt_BR |
dc.type |
Artigo |
pt_BR |